Valuation Decoy Therapeutics Inc.

Stocks

Real-time Estimate Cboe BZX 14:14:01 2026-08-31 EDT			5-day change	1st Jan Change
3.065 ^USD	+5.69%		-2.89%	-61.21%

08-12	Decoy Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-27	Decoy Therapeutics Demonstrates In Vitro Activity Of D-MAV Candidate Against Wild-Type Ebola Zaire Virus And Opens Exploratory Program To Design D-MAVs Against Filoviruses Including Ebola And Marburg	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	21.65	22.39	3.485	2.56	2.652	4.142
Change	-	3.4%	-84.43%	-26.55%	3.58%	56.21%
Enterprise Value (EV) ¹	11.01	-6.823	-8.621	-3.05	0.4389	-6.568
Change	-	-161.96%	-26.35%	64.62%	114.39%	-1,596.36%
P/E	-	-	-	-	-	-0.06x
PBR	-	0.58x	-	-	-	0.7x
PEG	-	-	-	-	-	-
Capitalization / Revenue	4.14x	12.2x	-	-	-	-
EV / Revenue	2.1x	-3.71x	-	-	-	-
EV / EBITDA	-1.42x	0.53x	0.38x	0.24x	-0.08x	1.61x
EV / EBIT	-1.41x	0.53x	0.38x	0.24x	-0.08x	1.6x
EV / FCF	-1.26x	1.76x	0.6x	0.34x	-0.15x	-3.6x
FCF Yield	-79.6%	57%	167%	295%	-674%	-27.7%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-	-	-	-	-	-129.1
Distribution rate	-	-	-	-	-	-
Net sales ¹	5.233	1.84	-	-	-	-
EBITDA ¹	-7.768	-12.79	-22.97	-12.88	-5.73	-4.089
EBIT ¹	-7.786	-12.81	-22.98	-12.89	-5.734	-4.096
Net income ¹	-7.352	-12.77	-31.61	-12.54	-5.576	-12.52
Net Debt ¹	-10.64	-29.21	-12.11	-5.61	-2.213	-10.71
Reference price ²	32,759.974	17,841.586	2,203.200	936.000	331.200	7.786
Nbr of stocks (in thousands)	0.66	1.26	1.58	2.74	8.01	532
Announcement Date	3/18/21	3/25/22	3/27/23	3/22/24	3/21/25	3/31/26

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
DECOY THERAPEUTICS INC.	-	-	-	-	1.9M
WUXI APPTEC CO., LTD.	20.59x	7.25x	14.66x	1.42%	69.54B
ARGENX SE	36.89x	9.62x	29.41x	0.04%	64.97B
WUXI BIOLOGICS (CAYMAN) INC.	30.69x	6.58x	17.2x	-.--%	26.51B
INSMED INCORPORATED	-72.56x	13.98x	-67.43x	-.--%	25.89B
BIONTECH SE	-15.61x	5.94x	-7.46x	-.--%	25.64B
PHARMAESSENTIA CORPORATION	58.27x	21.67x	43.95x	0.26%	20.22B
GENMAB A/S	27.27x	5.11x	16.98x	-.--%	19.98B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1415.29x	39.34x	858.54x	-.--%	15.69B
EXELIXIS, INC.	16.84x	5x	11.66x	-.--%	13.49B
Average	168.63x	12.72x	101.95x	0.19%	28.19B
Weighted average by Cap.	94.04x	10.79x	57.82x	0.38%